Altria takes US$4.1 billion charge on Juul investment, revises deal terms

Altria takes US$4.1 billion charge on Juul investment, revises deal terms

Altria Inc said on Thursday it recorded a US$4.1 billion charge in the fourth quarter for its investment in Juul Labs Inc, nearly three months after taking a US$4.5 billion charge in the e-cigarette maker.

A hand with a cigarette is seen in front of displayed logos of Philip Morris and Altria in this pic
FILE PHOTO: A hand with a cigarette is seen in front of displayed logos of Philip Morris and Altria in this picture illustration taken September 26, 2019. REUTERS/Dado Ruvic/Illustration

REUTERS: Altria Inc took another US$4 billion charge on its investment in Juul Labs Inc and said it had reworked its deal terms with the embattled e-cigarette maker, which is facing increased regulatory scrutiny amid a backlash against vaping.

The Marlboro maker said on Thursday the fourth-quarter charge was mainly for the increased number of legal cases pending against Juul and the expectation that the number will grow.

Overall, Altria has recorded US$8.6 billion in impairment charges after it took a 35per cent stake in Juul for US$12.8 billion in December 2018. These charges brought down the value of its investment to US$4.2 billion as of Dec. 31, Altria said.

Shares of Altria fell 5per cent in early trading after the company also posted a fourth-quarter loss of US$1.81 billion, compared with a profit US$1.25 billion.

With the Juul deal, Altria had set its sights on re-entering the market for vaping in the face of declining smoking rates and cigarette sales in the United States.

But a string of vaping-related deaths, coupled with increased bans following a surge in teenage vaping, has clouded Juul's future and shrunk its valuation since Altria bought the stake.

Altria said it would stop providing services including logistics, distribution and access to retail shelf space to Juul, while also outlining a plan to reshuffle the company's board once regulators complete the anti-trust probe related to the deal.

It will only help Juul with regulatory affairs services including the submission of its products for approval by the U.S. Food and Drug Administration, the company added.

In a bid to rebuild the e-cigarette maker's public image, Juul, under new chief executive officer and former Altria executive, K.C. Crosthwaite, has revamped its top management.

Altria also said Juul will restructure its board to include two directors designated by Altria after the completion of the probe.

"This agreement is a continuation of the reset initiated by JUUL's leadership team," Altria Chief Executive Officer Howard Willard said in a statement.

(Reporting by Aishwarya Venugopal in Bengaluru, additional reporting by Praveen Paramasivam; Editing by Bernard Orr)

Source: Reuters

Bookmark